The dexamethasone suppression test in depression--a Singapore study.

Area of Science:

• Psychiatry
• Neuroendocrinology
• Clinical Diagnostics

Background:

• The Dexamethasone Suppression Test (DST) is explored for its role as a biological marker.
• Depressive illness is a primary focus for DST evaluation in psychiatric research.

Purpose of the Study:

• To assess the efficacy of the Dexamethasone Suppression Test (DST) as a biological marker in major depressive disorder.
• To investigate DST response rates in patients diagnosed with major depressive disorder.

Main Methods:

• A study was conducted involving 20 patients meeting Research Diagnostic Criteria for major depressive disorder.
• Twenty-one healthy individuals served as controls for comparison.
• The Dexamethasone Suppression Test (DST) was administered to all participants.

Main Results:

• Two out of the 20 patients diagnosed with major depressive disorder demonstrated abnormal DST responses.
• The study provides preliminary data on DST abnormalities in a clinical depressive population.

Conclusions:

• The Dexamethasone Suppression Test (DST) may serve as a useful biological marker in the diagnosis and understanding of depressive illness.
• Further research is warranted to validate DST's role in psychiatric diagnostics.